Healthcare -
Biotechnology - NASDAQ - US
$ 3.32
-5.41 %
$ 636 M
Market Cap
-8.74
P/E
ABUS - REVENUE
Revenue ABUS - Arbutus Biopharma Corporation
6.17 M
LAST VALUE
-60.23%
2 YEAR CAGR
0.53%
5 YEAR CAGR
-8.50%
10 YEAR CAGR